How many institutions held AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in Q2 2017?

64 institutional investors reported AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value for Q2 2017. Use the holders table for investor-level position and value details.

Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

Q: What does CUSIP 05156V102 represent in this 13F holders report?

CUSIP 05156V102 is the security identifier for AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value used to aggregate holder disclosures.

CUSIP: 05156V102

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / Common Shares, no par value
Shares outstanding: 132,929,348
Total 13F shares: 23,175,243
Share change: -619,119
Total reported value: $142,270,544
Put/Call ratio: 148%
Price per share: $6.13
Number of holders: 64
Value change: -$8,837,055
Number of buys: 36
Number of sells: 37

Quarterly Holders Quick Answers

What is CUSIP 05156V102?
CUSIP 05156V102 identifies AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 05156V102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	4.4%	5,848,600	$42,928,000	—	31 Mar 2017	13F
NEA Management Company, LLC	13F	Company	3.6%	4,808,483	$35,294,000	—	31 Mar 2017	13F
ORBIMED ADVISORS LLC	13F	Company	1.4%	1,797,400	$13,193,000	—	31 Mar 2017	13F
FRANKLIN RESOURCES INC	13F	Company	0.94%	1,250,000	$9,175,000	—	31 Mar 2017	13F
GREAT POINT PARTNERS LLC	13F	Company	0.75%	1,000,000	$7,340,000	—	31 Mar 2017	13F
Alyeska Investment Group, L.P.	13F	Company	0.59%	790,192	$5,800,000	—	31 Mar 2017	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.57%	751,300	$5,515,000	—	31 Mar 2017	13F
Crawford Lake Capital Management, LLC	13F	Company	0.47%	618,400	$4,539,000	—	31 Mar 2017	13F
Vivo Capital, LLC	13F	Company	0.45%	600,000	$4,404,000	—	31 Mar 2017	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.41%	548,771	$4,028,000	—	31 Mar 2017	13F
MORGAN STANLEY	13F	Company	0.34%	446,135	$3,273,000	—	31 Mar 2017	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.3%	400,000	$2,936,000	—	31 Mar 2017	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	0.3%	400,000	$2,936,000	—	31 Mar 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.26%	346,645	$2,544,000	—	31 Mar 2017	13F
AWM Investment Company, Inc.	13F	Company	0.23%	300,000	$2,202,000	—	31 Mar 2017	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.23%	300,000	$2,202,000	—	31 Mar 2017	13F
Abingworth LLP	13F	Company	0.19%	252,129	$1,848,000	—	31 Mar 2017	13F
Nicholas Investment Partners, LP	13F	Company	0.19%	251,600	$1,846,000	—	31 Mar 2017	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.19%	251,475	$1,846,000	—	31 Mar 2017	13F
HIGHLAND CAPITAL MANAGEMENT LP	13F	Company	0.15%	200,000	$1,468,000	—	31 Mar 2017	13F
CREDIT AGRICOLE S A	13F	Individual	0.04%	57,103	$1,393,000	—	31 Mar 2017	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.14%	184,628	$1,355,000	—	31 Mar 2017	13F
OTA Financial Group L.P.	13F	Company	0.13%	175,934	$1,291,000	—	31 Mar 2017	13F
CITADEL ADVISORS LLC	13F	Company	0.13%	169,203	$1,242,000	—	31 Mar 2017	13F
Redmile Group, LLC	13F	Company	0.11%	140,243	$1,029,000	—	31 Mar 2017	13F
BANK OF MONTREAL /CAN/	13F	Company	0.09%	124,700	$915,000	—	31 Mar 2017	13F
S.c.a. Candriam	13F	Individual	0.09%	118,000	$866,000	—	31 Mar 2017	13F
UBS Group AG	13F	Company	0.08%	112,314	$824,000	—	31 Mar 2017	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.08%	105,700	$776,000	—	31 Mar 2017	13F
Virtu KCG Holdings LLC	13F	Company	0.08%	104,946	$770,000	—	31 Mar 2017	13F
IRONWOOD INVESTMENT MANAGEMENT LLC	13F	Company	0.08%	102,730	$754,000	—	31 Mar 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.07%	95,758	$703,000	—	31 Mar 2017	13F
Bank of New York Mellon Corp	13F	Company	0.06%	81,019	$595,000	—	31 Mar 2017	13F
Iguana Healthcare Management, LLC	13F	Company	0.06%	75,000	$551,000	—	31 Mar 2017	13F
Hikari Power Ltd	13F	Company	0.05%	60,000	$440,000	—	31 Mar 2017	13F
NumerixS Investment Technologies Inc	13F	Company	0.04%	54,655	$401,000	—	31 Mar 2017	13F
GROUP ONE TRADING LLC	13F	Company	0.04%	53,051	$389,000	—	31 Mar 2017	13F
Parallax Volatility Advisers, L.P.	13F	Company	0.04%	50,045	$367,000	—	31 Mar 2017	13F
Kazazian Asset Management, LLC	13F	Company	0.03%	45,000	$330,000	—	31 Mar 2017	13F
R&F Capital Advisors LP	13F	Company	0.03%	42,576	$313,000	—	31 Mar 2017	13F
A.R.T. Advisors, LLC	13F	Company	0.03%	39,400	$289,000	—	31 Mar 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.03%	38,400	$281,000	—	31 Mar 2017	13F
Quantbot Technologies LP	13F	Company	0.03%	37,554	$275,000	—	31 Mar 2017	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.03%	35,400	$260,000	—	31 Mar 2017	13F
Anson Funds Management LP	13F	Company	0.02%	29,900	$250,000	—	31 Mar 2017	13F
TD ASSET MANAGEMENT INC	13F	Company	0.02%	32,887	$241,000	—	31 Mar 2017	13F
TWO SIGMA SECURITIES, LLC	13F	Company	0.02%	32,652	$240,000	—	31 Mar 2017	13F
LPL Financial LLC	13F	Company	0.02%	30,002	$209,000	—	31 Mar 2017	13F
Cutler Group LLC / CA	13F	Company	0.02%	27,440	$201,000	—	31 Mar 2017	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	27,235	$200,000	—	31 Mar 2017	13F

Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q2 2017

As of 30 Jun 2017, Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,175,243 shares. The largest 10 holders included FMR LLC, NEA Management Company, LLC, ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, Polar Capital LLP, Vivo Capital, LLC, GOLDMAN SACHS GROUP INC, Alyeska Investment Group, L.P., MORGAN STANLEY, and Balyasny Asset Management LLC. This page lists 64 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

Q2 2017 holders

Holder diff

-7

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 Value $	Q2 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.